全文获取类型
收费全文 | 1191篇 |
免费 | 75篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 36篇 |
妇产科学 | 22篇 |
基础医学 | 226篇 |
口腔科学 | 16篇 |
临床医学 | 126篇 |
内科学 | 224篇 |
皮肤病学 | 19篇 |
神经病学 | 60篇 |
特种医学 | 98篇 |
外科学 | 93篇 |
综合类 | 71篇 |
一般理论 | 35篇 |
预防医学 | 87篇 |
眼科学 | 35篇 |
药学 | 69篇 |
肿瘤学 | 63篇 |
出版年
2021年 | 18篇 |
2020年 | 13篇 |
2019年 | 14篇 |
2018年 | 10篇 |
2016年 | 11篇 |
2015年 | 11篇 |
2014年 | 28篇 |
2013年 | 43篇 |
2012年 | 52篇 |
2011年 | 56篇 |
2010年 | 35篇 |
2009年 | 36篇 |
2008年 | 54篇 |
2007年 | 53篇 |
2006年 | 61篇 |
2005年 | 51篇 |
2004年 | 36篇 |
2003年 | 41篇 |
2002年 | 47篇 |
2001年 | 39篇 |
2000年 | 32篇 |
1999年 | 38篇 |
1998年 | 47篇 |
1997年 | 47篇 |
1996年 | 42篇 |
1995年 | 21篇 |
1994年 | 16篇 |
1993年 | 29篇 |
1992年 | 24篇 |
1991年 | 9篇 |
1990年 | 12篇 |
1989年 | 20篇 |
1988年 | 13篇 |
1987年 | 14篇 |
1986年 | 21篇 |
1985年 | 27篇 |
1984年 | 15篇 |
1983年 | 14篇 |
1982年 | 18篇 |
1981年 | 11篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1975年 | 10篇 |
1973年 | 12篇 |
1972年 | 6篇 |
1971年 | 7篇 |
1967年 | 6篇 |
1965年 | 5篇 |
1927年 | 6篇 |
排序方式: 共有1297条查询结果,搜索用时 93 毫秒
1.
2.
3.
4.
5.
J C H Miles G M Kendall Z-F Ibrahimi C B Howarth 《Journal of radiological protection》2004,24(2):165-171
Etched track detectors are widely used for the detection of radon and its decay products. They have many desirable attributes: they are small, cheap, simple, non-toxic and non-hazardous. Etched track detectors provide adequate accuracy for most radiological protection purposes provided stringent quality assurance is maintained. The UK validation scheme provides an important component of QA but continuous monitoring of conditions and results is also needed. If these conditions are observed, these detectors provide an entirely adequate tool for large-scale use in assessing levels of radon in houses. Accurate estimates of long-term average radon levels require a measurement over several months because of the short-term fluctuations in radon concentrations. 相似文献
6.
Douglas M. Howarth Martin T. Epstein Paul A. Thomas Leonard W. Allen Rachel Akerman Linda Lan 《European journal of nuclear medicine and molecular imaging》1997,24(12):1465-1469
The efficacy of fractionated out-patient radioiodine therapy in 38 patients with compressive symptoms due to long-standing
large multinodular goitres was assessed. The diagnosis was established by clinical assessment in addition to technetium-99m
pertechnetate thyroid scan or computed tomography scan of the thyroid and mediastinum. Oral iodine-131 therapy was administered
as a 2.22 GBq (60 mCi) cumulative dose over 4 months (555 MBq per month). All patients were monitored with serum thyroid-stimulating
hormone and free thyroxine (± free tri-iodothyronine) assays before the treatment and after each dose fraction. Clinical and
biochemical follow-up was performed on all patients and ranged from 6 to 45 months after therapy. The patients consisted of
35 female and three male patients with a median age of 59 years (range 37–87 years). Prior to treatment 20 patients were biochemically
hyperthyroid and 18 were euthyroid. Overall, 71% of patients reported a subjective improvement in compressive symptoms and
29% reported no change. Clinically assessed reduction in goitre size occurred in 92% of patients while there was no change
in 8%. At 3 months of follow-up, 31% of patients had become hypothyroid and at 18 months 66% were hypothyroid. Seven hyperthyroid
patients (35%) became euthyroid and 13 hyperthyroid patients (65%) became hypothyroid. Three patients who became hypothyroid
experienced neck soreness (transient in one patient, persistent in two patients). There were no differences in outcome between
patients who were hyperthyroid and those who were euthyroid prior to treatment. Fractionated out-patient radioiodine therapy
showed excellent short- and medium-term safety, was very well tolerated and offered a satisfactory alternative treatment to
surgery.
Received 23 May and in revised form 11 August 1997 相似文献
7.
8.
The processing of antigens delivered as DNA vaccines 总被引:2,自引:0,他引:2
Summary: The ability of DNA vaccines to provide effective immunological protection against infection and tumors depends on their ability to generate good CD4+ and CD8+ T‐cell responses. Priming of these responses is a property of dendritic cells (DCs), and so the efficacy of DNA‐encoded vaccines is likely to depend on the way in which the antigens they encode are processed by DCs. This processing could either be via the synthesis of the vaccine‐encoded antigen by the DCs themselves or via its uptake by DCs following its synthesis in bystander cells that are unable to prime T cells. These different sources of antigen are likely to engage different antigen‐processing pathways, which are the subject of this review. Understanding how to access different processing pathways in DCs may ultimately aid the rational development of plasmid‐based vaccines to pathogens and to cancer. 相似文献
9.
Effect of inhaled frusemide on responses of airways to bradykinin and adenosine 5'-monophosphate in asthma. 总被引:3,自引:3,他引:0
下载免费PDF全文
![点击此处可从《Thorax》网站下载免费的PDF全文](/ch/ext_images/free.gif)
BACKGROUND--Inhaled frusemide exerts a protective effect against bronchoconstriction induced by several indirect stimuli in asthma. This effect could be caused by interference with neural pathways. The effect of inhaled frusemide on bronchoconstriction induced by inhaled bradykinin, which is thought to cause bronchoconstriction via neural mechanisms, was studied and compared with the effects of adenosine 5'-monophosphate (AMP) which probably produces its airway effects by augmenting mast cell mediator release and interfering with neural pathways. METHODS--Patients first underwent AMP and bradykinin challenges. They were then studied in a randomised, placebo controlled, double blind fashion. Ten atopic asthmatic subjects, studied on four days, were pretreated with inhaled frusemide (40 mg) or placebo for 10 minutes, five minutes before challenge with increasing concentrations of nebulised AMP or bradykinin. RESULTS--On the open visit days the provocative concentrations required to reduce forced expiratory volume in one second (FEV1) by 20% from baseline (PC20) for AMP and bradykinin were 16.23 (1.42-67.16) and 2.75 (0.81-6.6) mg/ml. There was a significant correlation between baseline AMP and bradykinin PC20 values. For AMP the geometric mean PC20 values following pretreatment with inhaled frusemide and matched placebo were 80.97 (9.97- > 400.0) and 14.86 (2.6-104.6) mg/ml respectively (95% CI 0.49 to 0.98). For bradykinin the geometric mean PC20 values following pretreatment with inhaled frusemide and matched placebo were 13.22 (2.53- > 16.0) and 2.52 (0.45-5.61) mg/ml respectively (95% CI 0.43 to 1.01). Frusemide afforded 5.45 and 5.24 fold protection against AMP and bradykinin-induced bronchoconstriction respectively. Furthermore, there was a significant correlation between protection afforded to the airways against AMP and bradykinin. CONCLUSIONS--These data suggest that inhaled frusemide affords protection against bradykinin-induced bronchoconstriction which is comparable to that against AMP, supporting a common mechanism of action for frusemide. 相似文献
10.
Relative carriage rates of nuclear dehydrogenating clostridia in two populations of different colorectal cancer risk
下载免费PDF全文
![点击此处可从《Journal of clinical pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Carriage of nuclear dehydrogenating clostridia has been associated with colon cancer and implicated in its aetiology. This study has compared the carriage of these organisms in a British population at high risk for the development of colon cancer with a low risk Nigerian population. Clostridia were found in all of the stools from both populations. Nuclear dehydrogenating clostridia were only found in the stools of the British subjects (32%). These results support the suggestion that the carriage rate of nuclear dehydrogenating clostridia in a population is related to the risk of colon cancer. 相似文献